Bank of Montreal’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-950
| Closed | -$21K | – | 4447 |
|
|
2017
Q2 | $21K | Sell |
950
-1,184
| -55% | -$21.5K | ﹤0.01% | 3535 |
|
|
2017
Q1 | $30K | Sell |
2,134
-83,277
| -98% | -$1.36M | ﹤0.01% | 3253 |
|
|
2016
Q4 | $1.44M | Sell |
85,411
-288,470
| -77% | -$4.9M | ﹤0.01% | 1732 |
|
|
2016
Q3 | $6.17M | Sell |
373,881
-204,739
| -35% | -$3.03M | 0.01% | 1016 |
|
|
2016
Q2 | $7.78M | Sell |
578,620
-227,127
| -28% | -$3.31M | 0.01% | 921 |
|
|
2016
Q1 | $12.3M | Sell |
805,747
-72,917
| -8% | -$1.14M | 0.01% | 654 |
|
|
2015
Q4 | $17.4M | Buy |
878,664
+48,436
| +6% | +$920K | 0.02% | 533 |
|
|
2015
Q3 | $14.5M | Sell |
830,228
-89,991
| -10% | -$1.83M | 0.02% | 565 |
|
|
2015
Q2 | $18.6M | Buy |
920,219
+218,233
| +31% | +$4.21M | 0.02% | 545 |
|
|
2015
Q1 | $12.4M | Buy |
701,986
+696,025
| +11,676% | +$11.9M | 0.01% | 716 |
|
|
2014
Q4 | $97K | Sell |
5,961
-10,658
| -64% | -$196K | ﹤0.01% | 2797 |
|
|
2014
Q3 | $366K | Sell |
16,619
-2,744
| -14% | -$56.2K | ﹤0.01% | 2237 |
|
|
2014
Q2 | $390K | Buy |
19,363
+733
| +4% | +$12.4K | ﹤0.01% | 2215 |
|
|
2014
Q1 | $347K | Buy |
18,630
+7,095
| +62% | +$97.7K | ﹤0.01% | 2246 |
|
|
2013
Q4 | $116K | Buy |
11,535
+1,469
| +15% | +$17.8K | ﹤0.01% | 2482 |
|
|
2013
Q3 | $130K | Sell |
10,066
-1,315
| -12% | -$16.2K | ﹤0.01% | 2409 |
|
|
2013
Q2 | $135K | Buy |
+11,381
| New | +$123K | ﹤0.01% | 2324 |
|
Other funds holding AMRI
Bank of Montreal's AMRI Position: Q3 2017 in Review
Bank of Montreal sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 950 shares — an estimated $21K sold.
Bank of Montreal first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $18.6M in Q2 2015. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.
- Bank of Montreal reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
- Bank of Montreal sold 950 Albany Molecular Research Inc shares in Q3 2017, an estimated $21K.
- Bank of Montreal first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
- Bank of Montreal's Albany Molecular Research Inc position peaked at $18.6M in Q2 2015.
- 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.
Based on Bank of Montreal's 13F filing for Q3 2017, filed 16 Oct 2017.